Over 230 patients enrolled in potential registration-enabling trial in 1L HLA-A2-negative MUM, and median PFS readout targeted by year-end 202595 patients enrolled in neoadjuvant UM trial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback